US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

265.27

-0.7300-0.27%

Volume:193.95K

Turnover:52.06M

Market Cap:497.24M

PE:- -

High:278.96

Open:269.96

Low:262.59

Close:266.00

52wk High:341.93

52wk Low:74.95

Shares:1.87M

Float Shares:1.87M

Volume Ratio:0.90

T/O Rate:10.35%

Dividend:1.00

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ginkgo Bioworks Holdings (DNA) and Vericel (VCEL)

Bernstein Keeps Their Buy Rating on Humana (HUM)

Agilon Health (AGL) Receives a Hold from Bernstein

Thonburi Healthcare Names New Chairman

MT Newswires Live

Ionis Pharmaceuticals Gets FDA Approval for Alexander Disease Treatment

MT Newswires Live

Health Care Roundup: Market Talk

Max Healthcare to Infuse INR879 Million into Kalinga Hospital

MT Newswires Live

Humanwell Healthcare Subsidiary Gets China Clinical Trial Nod for Postoperative Pain Relief Tablets

MT Newswires Live

Regis Healthcare Director Sally Freeman Increases Shareholding

Bubs Australia Requests Trading Halt Ahead of FDA Update

Citi Group Ceases to Be Substantial Holder in Sonic Healthcare

Regis Healthcare Ltd. (REG) Receives a Buy from Macquarie

Sino Biopharma Gets US FDA Investigational New Drug Approval for Tumor Drug

MT Newswires Live

Health Care Flat on Rotation to Rate-Sensitive Sectors - Health Care Roundup

Health Care Roundup: Market Talk

Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference

PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference

Alector to Participate in Upcoming Healthcare Conferences

Xenon to Present at Wells Fargo Healthcare Conference

FDA approves Ionis drug to treat Alexander disease

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/LABU/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":265.27,"timestamp":1789154309106,"preClose":266,"halted":0,"volume":193948,"delay":0,"changeRate":-0.0027443609022557076,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"Trading","change":-0.73,"latestTime":"09-11 15:18:42 EDT","open":269.9644,"high":278.9613,"low":262.59,"amount":52057039.625599995,"amplitude":0.061546,"askPrice":265.8,"askSize":30,"bidPrice":265.13,"bidSize":30,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":266,"sharesOutstanding":3074486,"nav":278.651,"aum":522328218.83,"dividendRate":0.003787,"bidAskSpread":0.002964,"preHourTrading":{"tag":"盘前","latestPrice":274.69,"preClose":266,"latestTime":"09:28 EDT","volume":2486,"amount":673283.80262,"timestamp":1789133308224,"change":8.69,"changeRate":0.032669,"amplitude":0.031541},"postHourTrading":{"tag":"盘后","latestPrice":264.12,"preClose":266,"latestTime":"19:53 EDT","volume":1904,"amount":504475.6573,"timestamp":1789084425326,"change":-1.88,"changeRate":-0.007068,"amplitude":0.00782},"volumeRatio":0.895785,"impliedVol":0.8484,"impliedVolPercentile":0.1952},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.895785,"shares":1874486,"dividePrice":1.0045,"high":278.9613,"amplitude":0.061546,"preClose":266,"low":262.59,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":265.27,"eps":0,"divideRate":0.003787,"volume":193948,"delay":0,"ttmEps":0,"open":269.9644,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":305.86,"twentyDayClose":273.91,"sixtyDayClose":184.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664339299","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ginkgo Bioworks Holdings (DNA) and Vericel (VCEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339299","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664339299?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:30","pubTimestamp":1788521410,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ginkgo Bioworks Holdings (DNA) and Vericel (VCEL). Ginkgo Biowork...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-ginkgo-bioworks-holdings-dna-and-vericel-vcel-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-ginkgo-bioworks-holdings-dna-and-vericel-vcel-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4139","BK4137","XBI","BK4109","DNA","LU0128526141.USD","BK4121","BK4585","BK4588","LU0029874061.USD","XLV","HCSG","BK4581","VCEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664339551","title":"Bernstein Keeps Their Buy Rating on Humana (HUM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339551","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664339551?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:17","pubTimestamp":1788520629,"startTime":"0","endTime":"0","summary":"Bernstein analyst Lance Wilkes maintained a Buy rating on Humana today and set a price target of $425.00. Wilkes covers the Healthcare sector, focu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-keeps-their-buy-rating-on-humana-hum-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-keeps-their-buy-rating-on-humana-hum-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0170899867.USD","LU0348723411.USD","BK4154","LU1983260115.SGD","LABU","LU0238689110.USD","LU1093756325.SGD","XBI","BK4533","HUM","LU0390134368.USD","BK4581","XLV","LU0211331839.USD","LU0070302665.USD","LU0266013472.USD","SG9999014005.SGD","BK4566","LU0208291251.USD","BK4588","LU0417517546.SGD","FXH","BK4585","LU1093756168.USD","LU0256863811.USD","SG9999014021.USD","IHF","LU0320765489.SGD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664395373","title":"Agilon Health (AGL) Receives a Hold from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2664395373","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664395373?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:16","pubTimestamp":1788520588,"startTime":"0","endTime":"0","summary":"Bernstein analyst Lance Wilkes maintained a Hold rating on Agilon Health today and set a price target of $86.00. Wilkes covers the Healthcare secto...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/agilon-health-agl-receives-a-hold-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/agilon-health-agl-receives-a-hold-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","AGL","BK4196","BK4588","BK4539","XLV","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891335","title":"Thonburi Healthcare Names New Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891335","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891335?lang=en_us&edition=fundamental","pubTime":"2026-09-04 17:52","pubTimestamp":1788515544,"startTime":"0","endTime":"0","summary":"Thonburi Healthcare (SET:THG) named Paiboon Eksaengsri as its chairman, effective Sept. 5, according to a Friday filing with the Thailand Exchange.Eksaengsri succeeds Aurchat Kanjanapitak who will continue to serve as a director.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","XLV","LU0128526141.USD","BK4137","HCSG","BK4585","XBI","BK4588","LU0029874061.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664338703","title":"Ionis Pharmaceuticals Gets FDA Approval for Alexander Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2664338703","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664338703?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:23","pubTimestamp":1788510190,"startTime":"0","endTime":"0","summary":"Ionis Pharmaceuticals  said late Thursday the US Food and Drug Administration approved zanvastrotm, or zilganersen, to treat Alexander disease in pediatric and adult patients.The treatment will be available in the US in the coming weeks, according to the company.A zanvastrotm trial met its primary endpoint in individuals aged at least five years, with the 50-milligram dose showing \"statistically significant and clinically meaningful\" stabilization of gait speed, compared with control at week 61, Ionis said.Alexander disease is an ultra-rare, progressive and often fatal neurological disorder that can affect motor, cognitive, autonomic and gastrointestinal function.The company's shares were up 1.5% in premarket activity Friday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4585","BK4588","IONS","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877213","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877213","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877213?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:20","pubTimestamp":1788510000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0607 GMT - Hutchmed (China)'s deal with GSK appears to validate ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4581","XLV","BK4588","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664872173","title":"Max Healthcare to Infuse INR879 Million into Kalinga Hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2664872173","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664872173?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:17","pubTimestamp":1788509872,"startTime":"0","endTime":"0","summary":"Max Healthcare Institute's  board approved an additional investment of about 878.7 million Indian rupees in subsidiary Kalinga Hospital.The investment will be made through subscription of Kalinga Hospital shares on a rights basis and is expected to be completed within 15 days, according to a Thursday filing on Indian bourses.Shares of the company fell nearly 1% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU0029874061.USD","BK4581","XBI","LABU","BK4137","HCSG","BK4585","LU0128526141.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381830","title":"Humanwell Healthcare Subsidiary Gets China Clinical Trial Nod for Postoperative Pain Relief Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381830","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381830?lang=en_us&edition=fundamental","pubTime":"2026-09-04 13:51","pubTimestamp":1788501105,"startTime":"0","endTime":"0","summary":"Humanwell Healthcare  subsidiary Yichang Humanwell Pharmaceutical received clinical trial approval from China's National Medical Products Administration for its RFUS-949 tablets for postoperative pain.The trial will evaluate the efficacy and safety of the tablets for pain relief after abdominal surgery, according to a Friday filing with the Shanghai bourse.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0185","BK0028","BK0012","BK0188","HCSG","XBI","LABU","600079","BK4137","BK0239","LU0029874061.USD","LU0128526141.USD","BK4581","BK4588","XLV","BK4585","BK0096","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664359381","title":"Regis Healthcare Director Sally Freeman Increases Shareholding","url":"https://stock-news.laohu8.com/highlight/detail?id=2664359381","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664359381?lang=en_us&edition=fundamental","pubTime":"2026-09-04 13:47","pubTimestamp":1788500834,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Regis Healthcare Ltd. ( ($AU:REG) ). Regis Healthcare Ltd has reported a change in director Sally Margaret Free...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regis-healthcare-director-sally-freeman-increases-shareholding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regis-healthcare-director-sally-freeman-increases-shareholding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0029874061.USD","BK4581","XBI","LABU","BK4137","HCSG","BK4585","LU0128526141.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664386115","title":"Bubs Australia Requests Trading Halt Ahead of FDA Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2664386115","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664386115?lang=en_us&edition=fundamental","pubTime":"2026-09-04 11:47","pubTimestamp":1788493642,"startTime":"0","endTime":"0","summary":"Bubs Australia Ltd. ( ($AU:BUB) ) has shared an announcement. Bubs Australia Ltd, an ASX-listed infant nutrition producer, focuses on supplying inf...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bubs-australia-requests-trading-halt-ahead-of-fda-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bubs-australia-requests-trading-halt-ahead-of-fda-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664832583","title":"Citi Group Ceases to Be Substantial Holder in Sonic Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2664832583","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664832583?lang=en_us&edition=fundamental","pubTime":"2026-09-04 10:17","pubTimestamp":1788488266,"startTime":"0","endTime":"0","summary":"Sonic Healthcare Limited ( ($AU:SHL) ) has shared an announcement. Citigroup Global Markets Australia and its related Citi group entities have disc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/citi-group-ceases-to-be-substantial-holder-in-sonic-healthcare?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/citi-group-ceases-to-be-substantial-holder-in-sonic-healthcare?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTXO","BK4559","LU0130102774.USD","LU1244550494.USD","LU1244550577.SGD","LU2456880835.USD","LU1144417596.USD","LU0477156953.USD","LU0320765646.SGD","LU2462157665.USD","LU0098860793.USD","LU0072461881.USD","BK4581","BK4588","LU0314106906.USD","BK4585","LU0980610538.SGD","LU2236285917.USD","XLV","LU0162691827.USD","LU0170899867.USD","LU1506573853.SGD","LU1668664300.SGD","BK4207","BK4504","LU1074936037.SGD","LU1791807156.HKD","LU0203347892.USD","LU0052756011.USD","IYF","TFNS","LU2360032135.SGD","LU1201861249.SGD","LU1244550221.USD","LU0130517989.USD","LU0128525689.USD","LU1162221912.USD","LU0106831901.USD","LU2125154778.USD","BK4534","LU0310800965.SGD","LU1267930227.SGD","IE00BSNM7G36.USD","XBI","LU1366192091.USD","LU0203345920.USD","LU0648001328.SGD","LABU","LU2417539215.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664807592","title":"Regis Healthcare Ltd. (REG) Receives a Buy from Macquarie","url":"https://stock-news.laohu8.com/highlight/detail?id=2664807592","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664807592?lang=en_us&edition=fundamental","pubTime":"2026-09-04 07:35","pubTimestamp":1788478528,"startTime":"0","endTime":"0","summary":"In a report released today, from Macquarie maintained a Buy rating on Regis Healthcare Ltd., with a price target of A$5.90. In addition to Macquari...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/regis-healthcare-ltd-reg-receives-a-buy-from-macquarie-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/regis-healthcare-ltd-reg-receives-a-buy-from-macquarie-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REG","XLV","BK4585","BK4080","LABU","XBI","BK4231","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664028698","title":"Sino Biopharma Gets US FDA Investigational New Drug Approval for Tumor Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2664028698","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664028698?lang=en_us&edition=fundamental","pubTime":"2026-09-04 06:07","pubTimestamp":1788473269,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical (HKG:1177) unit Chia Tai Tianqing Pharmaceutical Group obtained investigational new drug approval for TQB6426 from the U.S. Food and Drug Administration.The drug is intended for advanced malignant tumors, according to a Thursday Hong Kong bourse filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ08YS42.EUR","BK1521","01177","BK4585","HK0000165453.HKD","BK1515","IE00BZ08YR35.GBP","BK1589","BK4588","IE00BZ08YT58.USD","BK1191","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664804329","title":"Health Care Flat on Rotation to Rate-Sensitive Sectors - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2664804329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664804329?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:54","pubTimestamp":1788468840,"startTime":"0","endTime":"0","summary":"Health-care companies were more or less flat as traders rotated into sectors with more to gain from a prolonged hold on the Fed funds rate.The health-care sector has outperformed the broad market in recent weeks, being somewhat insulated from jitters about inflation and interest rates.The SPDR Select Sector Health Care exchange-traded fund, which tracks the health-care industry group of the S&P 500, is up about 18% since June 1 while the S&P 500 is little changed.Shares of Ultragenyx plunged by roughly 45% after the biotech firm's gene therapy for a rare neuro-degenerative disease.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","SPDF","CGUS","BK4585","LGH","LABU","BK4581","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664804538","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2664804538","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664804538?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:50","pubTimestamp":1788468600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1219 ET [Dow Jones]--Gains in bitcoin through August have inspir","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4588","BK4581","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664801193","title":"Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664801193","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664801193?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465900,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Sept.  03, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transfo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3356243/0/en/wave-life-sciences-to-present-at-cantor-2026-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA","BK4137","XLV","LU0128526141.USD","HCSG","XBI","LABU","IE0009354923.USD","BK4505","BK4139","BK4581","LU0029874061.USD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664801154","title":"PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664801154","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664801154?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465900,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Sept.  03, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participa","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3356242/16261/en/pacbio-to-participate-in-the-morgan-stanley-24%E1%B5%97%CA%B0-annual-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","IE00BKVL7J92.USD","LU1720051017.SGD","LU1988902786.USD","LU0390134368.USD","LU0006306889.USD","BK4504","BK4137","HCSG","BK4581","LU0210528500.USD","LU0557290698.USD","LU2089283258.USD","LU1791710400.SGD","LU0234570918.USD","BK4127","IAI","KBWB","LU2023251221.USD","LU0320765646.SGD","LU2264538146.SGD","BK4588","LU1074936037.SGD","LU0882574139.USD","LU2089284900.SGD","IE00B3S45H60.SGD","BK4585","LU0225283273.USD","LU1791710582.SGD","XLV","LU2133065610.SGD","LU1244550577.SGD","LU2111349929.HKD","LU0795875169.SGD","LU1162221912.USD","LU1989772923.USD","LU1720051108.HKD","IE00BZ1G4Q59.USD","PACB","LU0528227936.USD","LU1732800096.USD","LU1244550221.USD","LU0267386448.USD","LU1064131342.USD","LU2028103732.USD","BK4534","XBI","LABU","LU0098860793.USD","LU0106261372.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664080119","title":"Alector to Participate in Upcoming Healthcare Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664080119","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664080119?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465900,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Sept.  03, 2026 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a biotechnology company focused on developing therapies to counteract the devastating progression of neur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3356259/0/en/alector-to-participate-in-upcoming-healthcare-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","BK4588","LU0029874061.USD","LABU","BK4581","BK4137","XLV","XBI","HCSG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664011638","title":"Xenon to Present at Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664011638","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664011638?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:01","pubTimestamp":1788465660,"startTime":"0","endTime":"0","summary":"VANCOUVER, BC and BOSTON, MA, Sept.  03, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical deve","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3356231/33485/en/xenon-to-present-at-wells-fargo-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","LU0162691827.USD","PGF","LU0149725797.USD","BK4559","LU0052756011.USD","LU0256863811.USD","XLV","LU0251142724.SGD","LU0211327993.USD","LU0648001328.SGD","LU0154236417.USD","LU1668664300.SGD","LU0310800379.SGD","LU2361044949.HKD","KBWB","LU0208291251.USD","TFNS","LU0477156953.USD","LU1074936037.SGD","LU1363072403.SGD","LABU","HCSG","IYF","IE00B19Z3B42.SGD","LU0128525689.USD","BK4585","BK4207","LU1814569148.SGD","BK4588","LU0130102774.USD","LU1267930227.SGD","LU1267930490.SGD","BK4581","LU0980610538.SGD","LU0942090050.USD","BK4137","LU0175139822.USD","LU0211328371.USD","LU1069347547.HKD","XBI","IE00B7SZLL34.SGD","LU0310800965.SGD","FTXO","LU0130517989.USD","LU0787776722.HKD","IE00B19Z3581.USD","LU0029874061.USD","LU1506573853.SGD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664809179","title":"FDA approves Ionis drug to treat Alexander disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2664809179","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664809179?lang=en_us&edition=fundamental","pubTime":"2026-09-04 03:56","pubTimestamp":1788465365,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration has approved Zanvastro injection for the treatment of Alexander disease in pediatric and adult patients. “Zan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-ionis-drug-to-treat-alexander-disease-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-ionis-drug-to-treat-alexander-disease-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":11,"totalSize":417,"code":"91000000","status":"200"}]}}